STE - STERIS plc

NYSE - NYSE Delayed Price. Currency in USD
114.56
-0.54 (-0.47%)
At close: 4:02PM EST

115.25 +0.69 (0.60%)
After hours: 4:26PM EST

Stock chart is not supported by your current browser
Previous Close115.10
Open116.46
Bid96.18 x 800
Ask0.00 x 800
Day's Range114.18 - 116.96
52 Week Range82.88 - 121.67
Volume429,736
Avg. Volume398,596
Market Cap9.68B
Beta (3Y Monthly)0.93
PE Ratio (TTM)31.12
EPS (TTM)3.68
Earnings DateFeb 5, 2019 - Feb 11, 2019
Forward Dividend & Yield1.36 (1.19%)
Ex-Dividend Date2018-11-27
1y Target Est133.50
Trade prices are not sourced from all markets
  • STERIS (STE) Dips on New Restructuring Plan, Layoff Decision
    Zacks5 days ago

    STERIS (STE) Dips on New Restructuring Plan, Layoff Decision

    STERIS (STE) aims to stop the production of the worst-hit products and move toward the existing manufacturing operations by fiscal 2020.

  • Why Is Steris (STE) Down 0.6% Since Last Earnings Report?
    Zacks6 days ago

    Why Is Steris (STE) Down 0.6% Since Last Earnings Report?

    Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • GlobeNewswire7 days ago

    STERIS Announces Targeted Restructuring Plan

    STERIS plc (STE) ("STERIS" or the "Company") today announced a targeted restructuring plan, which includes the closure of two manufacturing facilities, one in Brazil and one in England, as well as other actions including product rationalization. The Company will relocate the production of the impacted products to existing manufacturing operations during fiscal 2020. "As a result of reduced demand for certain products and overall capacity in our global manufacturing network, we will rationalize select product offerings and consolidate manufacturing of others," said Walt Rosebrough, STERIS`s President and Chief Executive Officer.

  • Thomson Reuters StreetEvents21 days ago

    Edited Transcript of STE earnings conference call or presentation 6-Nov-18 3:00pm GMT

    Q2 2019 STERIS plc Earnings Call

  • Is STERIS plc’s (NYSE:STE) ROE Of 10% Impressive?
    Simply Wall St.last month

    Is STERIS plc’s (NYSE:STE) ROE Of 10% Impressive?

    Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Read More...

  • Steris (STE) Hits Fresh High: Is There Still Room to Run?
    Zackslast month

    Steris (STE) Hits Fresh High: Is There Still Room to Run?

    Steris (STE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • See what the IHS Markit Score report has to say about Steris PLC.
    Markitlast month

    See what the IHS Markit Score report has to say about Steris PLC.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • STERIS (STE) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
    Zackslast month

    STERIS (STE) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y

    STERIS (STE) continues to gain from strength in all business segments in Q2.

  • Steris Corp (STE) Q2 2019 Earnings Conference Call Transcript
    Motley Foollast month

    Steris Corp (STE) Q2 2019 Earnings Conference Call Transcript

    STE earnings call for the period ending September 30, 2018.

  • Steris (STE) Q2 Earnings and Revenues Surpass Estimates
    Zackslast month

    Steris (STE) Q2 Earnings and Revenues Surpass Estimates

    Steris (STE) delivered earnings and revenue surprises of 1.85% and 3.35%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Presslast month

    Steris: Fiscal 2Q Earnings Snapshot

    On a per-share basis, the Derby, Britain-based company said it had profit of 91 cents. Earnings, adjusted for non-recurring costs, came to $1.10 per share. The results topped Wall Street expectations. ...

  • GlobeNewswirelast month

    STERIS Announces Financial Results for Fiscal 2019 Second Quarter

    DERBY, U.K.  - (November 6, 2018) - STERIS plc (STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2019 second quarter ended September 30, 2018.  Revenue as reported for the quarter increased 7% to $679.0 million compared with $634.2 million in the second quarter of fiscal 2018, with growth across all segments. Constant currency organic revenue (see Non-GAAP Financial Measures) growth was 9% for the second quarter of fiscal 2019.

  • Will Steris (STE) Beat Estimates Again in Its Next Earnings Report?
    Zackslast month

    Will Steris (STE) Beat Estimates Again in Its Next Earnings Report?

    Steris (STE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • GlobeNewswire2 months ago

    STERIS to Participate in the Stephens NY Investment Conference

    DERBY, U.K.  - October 23, 2018 - STERIS plc (STE) ("STERIS" or the "Company") announced that it will participate in the Stephens NY Investment Conference on Wednesday, November 7, 2018.   Michael J. Tokich, STERIS`s Senior Vice President and Chief Financial Officer, will present at 1:45 p.m. Eastern Time. A simultaneous webcast and replay of the Company`s presentation will be available on STERIS`s investor relations website at www.steris-ir.com. STERIS`s mission is to help our Customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe.

  • GlobeNewswire2 months ago

    STERIS to Announce Fiscal 2019 Second Quarter Financial Results on November 6, 2018

    DERBY, U.K.  - October 23, 2018- STERIS plc (STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2019 second quarter financial results at 10:00 a.m. Eastern Time on Tuesday, November 6, 2018.  The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. STERIS`s mission is to help our Customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe. The referenced conference call and related release may contain statements concerning certain trends, expectations, forecasts, estimates, or other forward-looking information affecting or relating to STERIS or its industry, products or activities that are intended to qualify for the protections afforded "forward-looking statements" under the Private Securities Litigation Reform Act of 1995 and other laws and regulations.

  • GlobeNewswire2 months ago

    Report: Developing Opportunities within Balchem, STERIS plc, Tableau Software, Werner Enterprises, Wabco, and Weis Markets — Future Expectations, Projections Moving into 2018

    NEW YORK, Oct. 22, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • The “Accelerators”: 13 Dividend Stocks With Rapidly Growing Payouts
    Kiplinger2 months ago

    The “Accelerators”: 13 Dividend Stocks With Rapidly Growing Payouts

    Dividend growth stocks are a time-honored tool for building wealth. Implementing a dividend growth strategy begins with identifying well-managed companies that have solid balance sheets and steadily rising earnings. After all, what company would hike dividends if they anticipated future earnings would decline? A major advantage of dividend growth investing is the likelihood of capturing some total return even if the share price stagnates. For instance, depending on the length of time held, dividends account for anywhere between 27% and 60% of the total return of the Standard & Poor's 500-stock index. Dividend growth investing also lets you leverage the exponential growth that comes from compounding of reinvested dividends, and it's a hedge against inflation, as rising payouts counter the effect of the dollar's shrinking purchasing power. Better still, dividend growth stocks also have been shown to outperform non-dividend payers and the overall market. While any dividend growth is better than no growth, the best scenario is a stock whose payout is actually accelerating; your yield on cost will rapidly rise, eventually overtaking and exceeding the yields of stocks with high but stagnant payouts. Here's a look at 13 "Dividend Accelerators": a group of well-known dividend stocks that have recently ramped up their payout growth. SEE ALSO: 16 High-Yielding Monthly Dividend Payers

  • See what the IHS Markit Score report has to say about Steris PLC.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Steris PLC.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • See what the IHS Markit Score report has to say about Steris PLC.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Steris PLC.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Simply Wall St.2 months ago

    Does STERIS plc (NYSE:STE) Look Attractive Based On These Two Valuation Methods?

    With so many different financial models generating different conclusions, choosing the most relevant one to value a company can be daunting. A prime example of conflicts between valuation models is Read More...

  • STERIS (STE) Strategic Growth Strong Amid Several Headwinds
    Zacks2 months ago

    STERIS (STE) Strategic Growth Strong Amid Several Headwinds

    STERIS (STE) impresses with favorable underlying market trends apart from new products and service offerings. Yet, a severe competition lurking beneath is worrisome for the company.

  • Why Is Steris (STE) Down 1.2% Since Last Earnings Report?
    Zacks3 months ago

    Why Is Steris (STE) Down 1.2% Since Last Earnings Report?

    Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • What You Must Know About STERIS plc’s (NYSE:STE) Financial Strength
    Simply Wall St.3 months ago

    What You Must Know About STERIS plc’s (NYSE:STE) Financial Strength

    Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as STERIS plc (NYSE:STE), with a market capitalization of US$9.73b, rarely draw their attention from the investing community.Read More...

  • STERIS (STE) Strategic Growth Strong, Competition a Woe
    Zacks4 months ago

    STERIS (STE) Strategic Growth Strong, Competition a Woe

    STERIS' (STE) beneficial underlying market trends along with new product and service offerings are impressive. Meanwhile, the company worries over facing a severe competition.